What is AARD's debt-to-equity?

AARD (AARD) reported debt-to-equity of 0× in Q1 2026.

How has AARD's debt-to-equity changed year-over-year?

AARD's debt-to-equity decreased by 18.7% year-over-year, from 0× to 0×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

AARD AARD Debt-to-equity

Debt-to-equity at other companies

AbbVieABBV

46.6×+38.6×

Relmada Therapeutics, Inc.RLMD

0.9×0.0×

Rhythm Pharmaceuticals, Inc.RYTM

0.9×-5.1×

Viking TherapeuticsVKTX

0×0.0×

ArvinasARVN

0×0.0×

Protagonist TherapeuticsPTGX

0×0.0×

Other financials

Income statement

See full

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

See full

Cash & equivalents$62.4M+136%

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

See full

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

See full

Market cap$124.35M-58.6%

Enterprise value$62.25M-77.4%

Returns & leverage

See full

Return on equity-58.8%—

Current ratio8.1×-17.8×

Where this comes from

Calculated from AARD’s reported figures.

total debt/total stockholders equity=0×

Based on the most recent quarter.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AARD's debt-to-equity?: AARD (AARD) reported debt-to-equity of 0× in Q1 2026.
How has AARD's debt-to-equity changed year-over-year?: AARD's debt-to-equity decreased by 18.7% year-over-year, from 0× to 0×.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.